Combination of withaferin-A and CAPE provides superior anticancer potency: Bioinformatics and experimental evidence to their molecular targets and mechanism of action AN Sari, P Bhargava, JK Dhanjal, JF Putri, N Radhakrishnan, S Shefrin, ... Cancers 12 (5), 1160, 2020 | 36 | 2020 |
Identification of a new member of mortaparib class of inhibitors that target mortalin and PARP1 HN Meidinna, S Shefrin, AN Sari, H Zhang, JK Dhanjal, SC Kaul, ... Frontiers in Cell and Developmental Biology 10, 918970, 2022 | 3 | 2022 |
Comparative computational and experimental analyses of some natural small molecules to restore transcriptional activation function of p53 in cancer cells harbouring wild type … S Shefrin, AN Sari, V Kumar, H Zhang, HN Meidinna, SC Kaul, R Wadhwa, ... Current Research in Structural Biology 4, 320-331, 2022 | 3 | 2022 |
Cucurbitacin-B inhibits cancer cell migration by targeting mortalin and HDM2: computational and in vitro experimental evidence H Huifu, S Shefrin, S Yang, Z Zhang, SC Kaul, D Sundar, R Wadhwa Journal of Biomolecular Structure and Dynamics 42 (5), 2643-2652, 2024 | 2 | 2024 |
Molecular insights into the binding interactions and energetics of the omicron spike variant with hACE2 and a neutralizing antibody V Kumar, S Shefrin, D Sundar Journal of Structural Biology 216 (2), 108087, 2024 | | 2024 |
Construction and characterization of a temperature-sensitive pRC4 replicon for Rhodococcus and Gordonia A Deedwania, S Karmakar, V Kumar, S Shefrin, D Sundar, P Srivastava Gene 896, 147990, 2024 | | 2024 |
Caffeic Acid Phenethyl Ester and Withaferin-A Combination Selectively Inhibits Ternary Complex Formed by p53, Mortalin and PARP1 D Sundar | | 2020 |